References
- SocranskySHaffajeeAEvidence of bacterial aetiology: a historical perspectivePeriodontol 2000199457259673160
- ArmitageGCDevelopment of a classification system for periodontal diseases and conditionsAnn Periodontol199941610863370
- PussinenPJVilkuna-RautiainenTAlfthanGSevere periodontitis enhances macrophage activation via increased serum lipopolysaccharideArterioscler Thromb Vasc Biol2004242174218015388525
- LiLKhansariAShapiraLContribution of interleukin-11 and prostaglandin(s) in lipopolysaccharide-induced bone resorption in vivoInfect Immun2002703915392212065535
- ChiangCYKyritsisGGravesDTInterleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharideInfect Immun1999674231423610417196
- PageRCThe microbiological case for adjunctive therapy for periodontitisJ Int Acad Periodontol2004614314915536782
- ZhaoNGeSHDingGYClinical effect of minocycline as adjunctive therapy to scaling and root planning on treatment of chronic periodontitisHua Xi Kou Qiang Yi Xue Za Zhi200624323516541651
- CortelliJRQueridoSMAquinoDRLongitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitisJ Periodontol20067716116616460239
- PaquetteDWRyanMEWilderRSLocally delivered antimicrobials: clinical evidence and relevanceJ Dent Hyg20083101519275823
- GopinathVRamakrishnanTEmmadiPEffect of a controlled release device containing minocycline microspheres on the treatment of chronic periodontitis: A comparative studyJ Indian Soc Periodontol200913798420407655
- SuntresZEShekPNProphylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in ratsBiochem Pharmacol2000591155116110704946
- RatnamDVRole of antioxidants in prophylaxis and therapy: a pharmaceutical perspectiveJ Control Release200611318920716790290
- OsawaMAndersonDEEricksonHPReconstitution of contractile FtsZ Rings in liposomesScience2008979279418420899
- PascaleDGordonILamsterIConcentration of doxycycline in human gingival fluidJ Clin Periodontol1986138418443537018
- WaltersJDNakkulaRJManeyPModulation of gingival fibroblast minocycline accumulation by biological mediatorsJ Dent Res20058432032315790736
- ParkSYParkDJKimYHSchisandra chinensis α-iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophagesInt Immunopharmacol2011111907191521840424
- LarsenTOccurrence of doxycycline resistant bacteria in the oral cavity after local administration of doxycycline in patients with periodontal diseaseScand J Infect Dis19912389952028232
- RobertsFAHockettRDBucyRPQuantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitisOral Microbiol Immunol1997123363449573807
- GamonalJAcevedoABasconesALevels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatmentJ Periodontol2000711535154511063385
- ThammasitboonKGoldringSRBochJARole of macrophages in LPS-induced osteoblast and PDL cell apoptosisBone20063884585216377271
- KumadaHHaishimaYUmemotoTStructural study on the free lipid A isolated from lipopolysaccharide ofPorphyromonas gingivalisJ Bacteriol1995177209821067721702
- YoshimuraAHaraYKanekoTSecretion of IL-1 beta, TNF-alpha, IL-8 and IL-1 alpha by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteriaJ Periodontal Res1997322792869138193
- VandekerckhoveBNQuirynenMvan SteenbergheDThe use of locally-delivered minocycline in the treatment of chronic periodontitis. A review of the literatureJ Clin Periodontol1998259649689839854
- ZinkMCUhrlaubJDeWittJNeuroprotective and anti-human immunodeficiency virus activity of minocyclineJAMA20052932003201115855434
- QueRPLiuXFQianQFA clinical study of periocline on the treatment of severe chronic periodontitisShanghai Kou Qiang Yi Xue20051425725915995772
- TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov2005414516015688077
- SamadASultanaYAqilMLiposomal drug delivery systems: an update reviewCurr Drug Deliv2007429730517979650
- JesorkaAOrwarOLiposomes: technologies and analytical applicationsAnn Rev Anal Chem20081801832
- BashaGNonobrantsevaTIRosinNInfluence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cellsMol Ther2011192186220021971424
- ReddyKRControlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugsJ Membrane Sci1997127223227
- MandalTKSwelling-controlled release system for the vagina delivery of miconazoleEur J Pharm Biopharm20005033734311072189
- JantzenGMRobinsonJRSustained and controlled-release drug delivery systemsBankerGSRhodesCTModern PharmaceuticsNew York, NYMarcel Dekker, Inc2002501528
- LuZChenWHammanJHChitosan–polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly watersoluble drugs I: in vitro evaluationDrug Dev Ind Pharm20103653954619877828
- MatsuoHWakasugiMTakanagaHPossibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoproteinJ Control Release201177778611689261
- NobiliSLandiniIGiglioniBPharmacological strategies for overcoming multidrug resistanceCurr Drug Targets2006786187916842217